|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-3-14
|
|
pubmed:abstractText |
To assess in a randomized study the therapeutic effect of the addition of high-dose L-asparaginase (HD ASP) in the context of a Berlin-Frankfurt-Münster (BFM)-based chemotherapy regimen for intermediate risk (IR) childhood acute lymphoblastic leukemia (ALL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AricòMM,
pubmed-author:Associazione Italiano Ematologia Oncologia Pediatrica,
pubmed-author:BarisoneEE,
pubmed-author:BassoGG,
pubmed-author:CasaleFF,
pubmed-author:ConterVV,
pubmed-author:Lo NigroLL,
pubmed-author:MaseraGG,
pubmed-author:RizzariCC,
pubmed-author:RondelliRR,
pubmed-author:SantoroNN,
pubmed-author:TestiAA,
pubmed-author:ValsecchiM GMG
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1297-303
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11230471-Adolescent,
pubmed-meshheading:11230471-Antineoplastic Agents,
pubmed-meshheading:11230471-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11230471-Asparaginase,
pubmed-meshheading:11230471-Child,
pubmed-meshheading:11230471-Child, Preschool,
pubmed-meshheading:11230471-Disease-Free Survival,
pubmed-meshheading:11230471-Female,
pubmed-meshheading:11230471-Humans,
pubmed-meshheading:11230471-Infant,
pubmed-meshheading:11230471-Infant, Newborn,
pubmed-meshheading:11230471-Injections, Intramuscular,
pubmed-meshheading:11230471-Male,
pubmed-meshheading:11230471-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11230471-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
|
|
pubmed:affiliation |
Clinica Pediatrica dell'Università di Milano, Ospedale S. Gerardo, Monza, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
